UBS Comments on Best Buy (BBY)
Get Alerts BBY Hot Sheet
Price: $76.01 +1.71%
Rating Summary:
7 Buy, 24 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
7 Buy, 24 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
UBS maintained a Neutral rating on Best Buy (NYSE: BBY) and cut its price target to $12.50 (from $14.50).
Commenting on Best Buy's recent quarterly report, analysts said "With each passing quarter, it seems like BBY's array of challenges are becoming more intense."
Analysts think that as BBY's operating margin declines and free cash flow shrinks, it will have less room to invest in its business.
"Whether it's the stodgy product cycle, the mix shift to lower margin products or the intense competition, we find it hard to believe that BBY can address these issues simply by executing better," concluded UBS.
For an analyst ratings summary and ratings history on Best Buy click here. For more ratings news on Best Buy click here.
Shares of Best Buy closed at $11.96 yesterday.
Commenting on Best Buy's recent quarterly report, analysts said "With each passing quarter, it seems like BBY's array of challenges are becoming more intense."
Analysts think that as BBY's operating margin declines and free cash flow shrinks, it will have less room to invest in its business.
"Whether it's the stodgy product cycle, the mix shift to lower margin products or the intense competition, we find it hard to believe that BBY can address these issues simply by executing better," concluded UBS.
For an analyst ratings summary and ratings history on Best Buy click here. For more ratings news on Best Buy click here.
Shares of Best Buy closed at $11.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Reiterates Hold Rating on Best Buy (BBY)
- UnitedHealth Group (UNH) PT Lowered to $197 at TD Cowen
- Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share